Cystic fibrosis: desensitization in delayed hypersensitivity reactions to elexacaftor/tezacaftor/ivacaftor

Background: Cystic fibrosis transmembrane conductance regulator modulators are the only available treatment for cystic fibrosis. Although elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) is well-tolerated, rash has been reported as very frequent. In severe rashes, ELX/TEZ/IVA withdrawal is necessary,...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	L. Gómez-Ganda, P. Galván-Blasco, A. Fernández-Polo, V. Cardona, B. García-Palop, CJ Parramón-Teixidó, E. Polverino, A. Álvarez-Fernández
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2024-06-01
Serier:	Frontiers in Pharmacology
Fag:	cystic fibrosis cystic fibrosis transmembrane conductance regulator modulator delayed hypersensitivity desensitization elexacaftor/tezacaftor/ivacaftor rash
Online adgang:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1392986/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!